ArticleFrontiers in medicine2026
Machine learning model for predicting the risk of AKI in early hemodynamically stable sepsis patients: a study based on the MIMIC IV database.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The increasing prevalence and mortality of sepsis and acute kidney injury (AKI) pose significant threats to the survival of critically ill patients worldwide. Consequently, it's essential to identify patients with sepsis-associated AKI early and to ascertain its risk factors. This study developed a machine learning (ML) model to identify patients at high risk of AKI among the hemodynamically stable sepsis. Methods: This study extracted clinical data from hemodynamically stable sepsis patients in the MIMIC IV Database for analysis, and collected clinical data from a hospital for external validation. The patients were randomly divided into a training set (70%) and a testing set (30%). Potential risk factors were screened out through univariate analysis and LASSO regression. Subsequently, models were constructed using Classification and Regression Tree, Gradient Boosting Machine, Logistic Regression, Random Forest, and Extreme Gradient Boosting (XGBoost). The performance of these models was assessed to determine the optimal predictive model. Results: A total of 8,276 hemodynamically stable sepsis patients were included in this study, among whom 3,061 patients (37%) experienced AKI. Nine risk factors were identified for model development using 70% of the data for training. By evaluating the model performance based on indicators including AUC, accuracy, sensitivity, kappa value, MCC, F1 score, Brier score, and DCA curve, the model constructed by XGBoost demonstrated the optimal performance. The external validation was consistent with the results. Conclusion: The XGBoost model exhibited optimal performance, and is suitable for predicting the risk of AKI in early hemodynamically stable sepsis patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.